Safety of recombinant human growth hormone in treating children with growth hormone deficiency and idiopathic short stature / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 123-126, 2011.
Article
in English
| WPRIM
| ID: wpr-341445
ABSTRACT
Recombinant human growth hormone is generally safe in treating children with growth hormone deficiency and idiopathic short stature. However, side effects such as sodium and water retention, benign intracranial hypertension, insulin insensitivity, increasing risk of secondary neoplasm, scoliosis, and slipped capital femoral epiphysis may occur occasionally, although the overall incidence remains low.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Recombinant Proteins
/
Human Growth Hormone
/
Therapeutic Uses
/
Drug Therapy
/
Dwarfism
/
Dwarfism, Pituitary
Limits:
Humans
Language:
English
Journal:
Acta Academiae Medicinae Sinicae
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS